Medical Instruments & Supplies · Healthcare
COO, CEO, Chairman
2021-11-04–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Biolife Solutions Inc publishes a filing, an earnings call transcript or a press release.
Get BLFS alertsRoderick de Greef is recorded as Chairman at Biolife Solutions Inc (BLFS) since October 19, 2023 and COO and CEO at Biolife Solutions Inc (BLFS). The newest filing on record that lists Roderick de Greef as CEO at Biolife Solutions Inc (BLFS) is dated July 8, 2025. The newest filing on record that lists Roderick de Greef as COO at Biolife Solutions Inc (BLFS) is dated June 6, 2023. Biolife Solutions Inc reported in an 8-K filed October 6, 2026 that Roderick de Greef resigned as named executive officer, effective October 6, 2026. Biolife Solutions Inc reported in an 8-K filed October 23, 2023 that Roderick de Greef was appointed Chief Executive Officer. Biolife Solutions Inc reported in an 8-K filed October 23, 2023 that Roderick de Greef was appointed Chairman of the Board of Directors. Equibles holds 7 filed executive changes naming Roderick de Greef; each is listed under recent activity with its source filing. The proxy statement of Biolife Solutions Inc reports total compensation of $7,046,205 for Roderick de Greef in fiscal 2024, including a base salary of $744,450. Disclosed compensation is on record for 7 fiscal years. Roderick de Greef has spoken on 10 earnings calls across 1 company, most recently for Biolife Solutions Inc on May 7, 2026. Biolife Solutions Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Biolife Solutions Inc includes Troy Wichterman (CFO), Maurice "Dusty" Tenney (COO), Sean Werner (CTO) and 7 others.
“Effective as of the First Merger Effective Time, each of Roderick de Greef, Troy Wichterman, Aby J. Mathew, Todd Berard and Sean Warner, comprising all of BioLife's named executive officers, resigned from their respective positions with BioLife.”
“Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately.”
“Good afternoon, everyone, and thank you for joining us for BioLife's First Quarter 2026 Conference Call. We're off to a solid start to 2026 with first quarter revenue growth of 25% and adjusted EBITDA up approximately 15% versus the prior year.”
“Good afternoon and thank you for joining us for BioLife's fourth quarter and full-year 2025 conference call. 2025 was another strong year for BioLife, delivering double-digit revenue growth, operating margin expansion, and improved profitability.”
“Good afternoon, and thank you for joining us for BioLife's Third Quarter 2025 Conference Call. We delivered another strong quarter, and we are raising our full year 2025 guidance as our team continues to execute and build on the momentum we've seen develop over recent quarters.”
“Good afternoon, and thank you for joining us for BioLife's Second Quarter 2025 Conference Call. We delivered another strong quarter as our team continues to execute and build on the momentum established over the last several quarters.”
“Good afternoon and thank you for joining us for BioLife's first quarter 2025 conference call. The first quarter marked a strong start to 2025, meeting our expectations as we continue to execute our strategic priorities and build on the momentum of 2024.”
2023-10-19–present
Start not stated–present
Last confirmed June 6, 2023
Start not stated–present
Last confirmed July 8, 2025
2021-11-04–2023-01-03
Start not stated–2023-06-06
Last confirmed by a filing; no departure on record
Start not stated–2021-12-31
Start not stated–2023-01-03
Medical Instruments & Supplies · Healthcare
COO, CEO, Chairman
2021-11-04–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Biolife Solutions Inc (BLFS) | Chief Executive Officer and Chairman of the Board | $744,450 | $7,046,205 |
| 2023 | Biolife Solutions Inc (BLFS) | Chief Executive Officer and Chairman of the Board | $198,890 | $5,316,798 |
| 2022 | Biolife Solutions Inc (BLFS) | Chief Executive Officer and Chairman of the Board | $450,000 | $2,383,673 |
| 2021 | Biolife Solutions Inc (BLFS) | Chief Executive Officer and Chairman of the Board | $412,137 | $1,180,590 |
| 2020 | Biolife Solutions Inc (BLFS) | Chief Operating Officer and President | $390,889 | $3,054,078 |
| 2019 | Biolife Solutions Inc (BLFS) | Chief Operating Officer and President | $402,500 | $1,155,548 |
| 2018 | Biolife Solutions Inc (BLFS) | Chief Operating Officer and Chief Financial Officer | $350,000 | $489,998 |